Open AccessCrossed Cerebellar Tracer Uptake on Acute-Stage 123I-Iomazenil SPECT Imaging Predicts 3-Month Functional Outcome in Patients With Nonfatal Hypertensive Putaminal or Thalamic Hemorrhage
Author(s) -
Daigo Kojima,
Nobukazu Komoribayashi,
Shinichi Omama,
Kohki Oikawa,
Shunrou Fujiwara,
Masatoshi Kobayashi,
Yoshitaka Kubo,
Kazunori Terasaki,
Kuniaki Ogasawara
Publication year - 2018
Publication title -
clinical nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.637
H-Index - 57
eISSN - 1536-0229
pISSN - 0363-9762
DOI - 10.1097/rlu.0000000000002068
Subject(s) - medicine , nuclear medicine , cerebellar hemisphere , spect imaging , perfusion , single photon emission computed tomography , modified rankin scale , cerebellum , cardiology , radiology , ischemia , ischemic stroke
Whereas SPECT images obtained 180 minutes after administration of I-iomazenil (IMZ) (late images) are proportional to the distribution of central benzodiazepine receptor-binding potential, SPECT images obtained within 30 minutes after I-IMZ administration (early images) correlate with regional brain perfusion. The aim of the present study was to determine whether crossed cerebellar tracer uptake on acute-stage I-IMZ SPECT imaging predicts 3-month functional outcome in patients with nonfatal hypertensive putaminal or thalamic hemorrhage.